Full Length Research Paper
References
|
Berna M, Murphy AT, Wilken B, Ackermann B (2002). Collection, storage, and filtration of in vivo study samples using 96-well filter plates to facilitate automated sample preparation and LC/MS/MS analysis. Anal. Chem. 74:1197-1201. Crossref |
||||
|
Black JW, Crowther AF, Shanks RG, Smith LH, Dornhorst AC (1964). A new adrenergic beta-receptor antagonist. Lancet. 1:1080-1081. Crossref |
||||
|
Braza AJ, Modamio P, Marino EL (2000). Two reproducible and sensitive liquid chromatographic methods to quantify atenolol and propranolol in human plasma and determination of their associated analytical error functions. J. Chromatogr. B Biomed. Sci. Appl. 738:225-231. Crossref |
||||
|
Delamoye M, Duverneuil C, Paraire F, de Mazancourt P, Alvarez JC (2004). Simultaneous determination of thirteen beta-blockers and one metabolite by gradient high-performance liquid chromatography with photodiode-array UV detection. Forensic Sci. Int. 141:23-31. Crossref |
||||
|
El-Saharty YS (2003). Simultaneous high-performance liquid chromatographic assay of furosemide and propranolol HCL and its application in a pharmacokinetic study. J. Pharm. Biomed. Anal. 33:699-709. Crossref |
||||
|
EMEA (2010). Guideline on the investigation of bioequivalence, Committee for medicinal products for human use (CHMP). London : European Medicines Agency. |
||||
|
Fagan TC, Walle T, Walle UK, Conradi EC, Harmon G, Gaffney TE (1982). Early kinetics of intravenous propranolol. Br. J. Clin. Pharmacol. 13:571-574. PubMed |
||||
|
FDA (2001). FDA Guidance for industry: Bioanalytical Method Validation. In: US Department of Health and Human Services,Center for Drug Evaluation and Research and center for Veterinary Medicine. Food and Drug Administration. Rockville, MD, USA. |
||||
|
Gage R, Stopher DA (1998). A rapid HPLC assay for voriconazole in human plasma. J. Pharm. Biomed. Anal. 17:1449-1453. Crossref |
||||
|
Hedeen KM, Tyczkowska K, Aucoin DP, Norton RM (1991). Rapid high-performance liquid chromatographic method for the determination of propranolol levels in canine and feline plasma. J. Chromatogr. 572:239-245. Crossref |
||||
|
Hefnawy MM, Asiri YA, Al-Zoman NZ, Mostafa GA, Aboul-Enein HY (2011). Stereoselective HPLC analysis of tertatolol in rat plasma using macrocyclic antibiotic chiral stationary phase. Chirality 23:333-338. Crossref |
||||
|
Jayewardene AL, Kearney B, Stone JA, Gambertoglio JG, Aweeka FT (2001). An LC-MS-MS method for the determination of indinavir, an HIV-1 protease inhibitor, in human plasma. J. Pharm. Biomed. Anal. 25:309-317. Crossref |
||||
|
Kim HK, Hong JH, Park MS, Kang JS, Lee MH (2001). Determination of propranolol concentration in small volume of rat plasma by HPLC with fluorometric detection. Biomed. Chromatogr. 15:539-545. Crossref |
||||
|
Koshakji RP, Wood AJ (1986). A modified, sensitive liquid chromatographic method for measurement of propranolol with fluorescence detection. J. Pharm. Sci. 75:87-89. Crossref |
||||
|
Masubuchi Y, Kagimoto N, Narimatsu S, Fujita S, Suzuki T (1993). Regioselective contribution of the cytochrome P-450 2D subfamily to propranolol metabolism in rat liver microsomes. Drug Metab. Dispos. 21:1012-1016. PubMed |
||||
|
Mislanova C, Hutta M (2003). Role of biological matrices during the analysis of chiral drugs by liquid chromatography. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 797:91-109. Crossref |
||||
|
Mullett WM (2007). Determination of drugs in biological fluids by direct injection of samples for liquid-chromatographic analysis. J. Biochem. Biophys. Methods. 70:263-273. Crossref |
||||
|
Ranta VP, Toropainen E, Talvitie A, Auriola S, Urtti A (2002). Simultaneous determination of eight beta-blockers by gradient high-performance liquid chromatography with combined ultraviolet and fluorescence detection in corneal permeability studies in vitro. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 772:81-87. Crossref |
||||
|
Rekhi GS, Jambhekar SS, Souney PF, Williams DA (1995). A fluorimetric liquid chromatographic method for the determination of propranolol in human serum/plasma. J. Pharm. Biomed. Anal. 13:1499-1505. Crossref |
||||
|
Rosseel MT, Bogaert MG (1981). High-performance liquid chromatographic determination of propranolol and 4-hydroxypropranolol in plasma. J. Pharm. Sci. 70:688-689. Crossref |
||||
|
Satinsky D, Serralheiro HS, Solich P, Araujo AN, Montenegro MC (2007). On-line coupling of sequential injection extraction with restricted-access materials and post-column derivatization for sample clean-up and determination of propranolol in human plasma. Anal. Chim. Acta. 600:122-128. Crossref |
||||
|
Shin J, Johnson JA (2007). Pharmacogenetics of β-blockers. Pharmacotherapy 27:874-887. Crossref |
||||
|
Silber BM, Holford NH, Riegelman S (1983). Dose-dependent elimination of propranolol and its major etabolites in humans. J. Pharm. Sci. 72:725-732. Crossref |
||||
|
Souverain S, Rudaz S, Veuthey JL (2004). Restricted access materials and large particle supports for on-line sample preparation: an attractive approach for biological fluids analysis. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 801:141-156. Crossref |
||||
| Summit Research Services (2005). PK Solutions version 2.0, noncompartmental pharmacokinetic analysis program, Colorado 81401: Montrose, USA, 2005. | ||||
|
Thompson JA, Hull JE, Norris KJ (1981). Glucuronidation of propranolol and 4'-hydroxypropranolol. Substrate specificity and stereoselectivity of rat liver microsomal glucuronyltransferases. Drug Metab. Dispos. 9:466-471. PubMed |
||||
| Vukovic G, Stereva D, Bursić V, Mladenova R, Lazić S (2012). Application of GC-MSD and LC-MS/MS for the determination of priority pesticides in baby foods in Serbian market, LWT – Food Sci. Technol. 49:312-319. | ||||
|
Walle T, Walle UK, Olanoff LS (1985). Quantitative account of propranolol metabolism in urine of normal man. Drug Metab. Dispos. 13:204-209. PubMed |
||||
|
Walshe M, Kelly MT, Smyth MR (1996). Comparison of two extraction methods for determination of propranolol and furosemide in human plasma by mixed-mode chromatography. J. Pharm. Biomed. Anal. 14:475-481. Crossref |
||||
|
Wersinger SR, Martin LB (2009). Optimization of laboratory conditions for the study of social behavior. ILAR J. 50:64-80. Crossref |
||||
|
Winek CL (1976). Tabulation of therapeutic, toxic, and lethal concentrations of drugs and chemicals in blood. Clin. Chem. 22:832-836. PubMed |
||||
|
Wolf-Coporda A, Plavsic F, Vrhovac B (1987). Determination of biological equivalence of two atenolol preparations. Int. J. Clin. Pharmacol. Ther. Toxicol. 25:567-571. PubMed |
||||
|
Zhou Q, Yao TW, Zeng S (2002). Chiral reversed phase high-performance liquid chromatography for determining propranolol enantiomers in transgenic Chinese hamster CHL cell lines expressing human cytochrome P450. J. Biochem. Biophys. Methods. 54:369-376. Crossref |
||||
Copyright © 2025 Author(s) retain the copyright of this article.
This article is published under the terms of the Creative Commons Attribution License 4.0
